You are on page 1of 3

Registry on Acute ST-elevation Myocardial Infarction in Januari – June 2020 at RSUD

Bangkinang

A. Rahmat1, P. Yeantesa2
1
General Pratitioner in RSUD Bangkinang, Bangkinang, Indonesia. 2Cardiologist in
RSUD Bangkinang, Bangkinang, Indonesia.

Background
Proper management is needed in treating ST- Elevation Myocard Infarction (STEMI) patients
to reduce morbidity and mortality due to myocardial infarction even in non PCI capable peripheral
hospitals. Early reperfusion management should be performed to limit the extent of myocardial
damage unless clear contraindications are present. The aim of this study is to gather data on the
characteristics, management and outcomes of patients hospitalized for STEMI in first semester of
2020 in RSUD Bangkinang.

Methods
Consecutive patients with STEMI who treated since cardiovascular services began operating
in RSUD Bangkinang were included. Patients referred for primary PCI were excluded from the study.
This was a descriptive retrospective study in patient with STEMI who underwent hospitalization in
RSUD Bangkinang from January to June 2020.

Results
A total of 18 patients were included over the entire recruitment period, mean age was 55,89 ±
10,64 years , 72,22% patients were men, 72,22% patients came to emergency departement within 12
hours onset, 44,44% were inferior STEMI, only 27,78% received intravenous fibrinolysis, smoking
66,67% was the most common risk factor among all patient. Aspirin, clopidogrel, statin, and low
weight molecular heparin were given to all patient. Heart failure 61,11% became the most common
complication in these patient. Only one patient died during treatment.

Conclusion
The first semester of Cardiovascular services in RSUD Bangkinang gave positif effect for
outcome in management of STEMI patient. Although there are still many patients management that
was incompatible with guidelines due to several reasons, cardiovascular services at RSUD
Bangkinang have begun to facilitate cardiac patients who wish to remain treated in this place,
especially for patients with acute myocardial infarction who need immediate management.

Keywords
STEMI management, Revascularization, RSUD Bangkinang
Table 1. Patient Baseline Characteristic, Medications and Outcome

Variable n (%)

Sex n = 18
Male 13 (72,22)
Female 5 (27,78)

Mean Age 55,89 ± 10,64

STEMI Site
Anterior 6 (33,33)
Anterolateral 3 (16,67)
Inferior 8 (44,44)
InferoPosterior 1 (5,56)

Onset
≤12 Hours
>12 Hours 13 (72,22)
5 (27,78)
Risk Factors
Diabetes
Hypertension 8 (44,44)
Dislipidemia 9 (50,00)
Smoking 7 (38,89)
12 (66,67)
Medications
Aspirin
Clopidogrel 18 (100)
Nitratets 18 (100)
Statin 16 (88,89)
ACE inhibitor 18 (100)
ARB 8 (44,44)
Beta Blockers 3 (16,67)
CCB 7 (38,89)
Morfin 1 (5,56)
Diuretic 2 (11,11)
LWMH 9 (50,00)
Amiodaron 18 (100)
Digoxin 1 (5,56)
Insulin 2 (11,11)
Nor-Ephinefrin 8 (44,44)
Dobutamin 5 (27,78)
Fibrinolitic 3 (16,67)
5 (27,78)
Complications
Arrhytmia
Heart Failure 2 (11,11)
Cardiogenic shock 11 (61,11)
Cardiac arrest 5 (27,78)
1 (5,56)
Outcome
Survive
Death 17 (94,44)
1 (5,56)

You might also like